United States Biotechnology & Medical Research

Context Therapeutics Inc (CNTX)

Track

Context Therapeutics Inc. experienced notable insider trading activity in June 2025, when key executives including the CEO, CFO, and Chief Legal Officer acquired shares. These purchases represent the most recent recorded transactions. Prior to this period, the company saw various planned acquisitions by leadership throughout early 2023 and late 2022.
Ticker: CNTX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Context Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
141.88
Quantity 32,890 -26.7%
Value US$4,802,219
2.3
Minai-Azary Jennifer Lynn Chief Financial Officer Officer
Transaction date
Purchase
Price
458.05
Quantity 29,734 -15.3%
Value US$902,376
3.3
Levit Alex C. Chief Legal Officer, Corp. Sec Officer
Transaction date
Purchase
Price
190.36
Quantity 11,028 +47.9%
Value US$801,276
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.84
Quantity 5,823 +3.8%
Value US$4,900
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.87
Quantity 5,606 +3.8%
Value US$4,901
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.97
Quantity 5,040 +3.5%
Value US$4,900
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.70
Quantity 7,027 +5.2%
Value US$4,901
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.72
Quantity 6,839 +5.3%
Value US$4,901
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Planned purchase
Price
0.74
Quantity 6,783 +5.5%
Value US$4,995
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.74
Quantity 20,000 +19.5%
Value US$14,796
2.3
Minai-Azary Jennifer Lynn Chief Financial Officer Officer
Transaction date
Purchase
Price
0.74
Quantity 25,000 +166.7%
Value US$18,500
3.3
Levit Alex C. Chief Legal Officer, Corp. Sec Officer
Transaction date
Purchase
Price
0.85
Quantity 6,000 +200.0%
Value US$5,095
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.85
Quantity 13,000 +14.5%
Value US$24,064
2.3
Minai-Azary Jennifer Lynn Chief Financial Officer Officer
Transaction date
Purchase
Price
1.80
Quantity 15,000 +inf%
Value US$27,000
0.5
Sahmoud Tarek Chief Medical Officer Officer
Transaction date
Purchase
Price
1.95
Quantity 10,000 +inf%
Value US$19,500
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.22
Quantity 13,000 +1.6%
Value US$41,850
3.3
Levit Alex C. Chief Legal Officer, Corp. Sec Officer
Transaction date
Purchase
Price
5.00
Quantity 3,000 +inf%
Value US$15,000
2.2
Lehr Martin A. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.00
Quantity 10,000 +11.2%
Value US$50,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-10 2025-06-09 B Purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
32,890 -26.7%
141.88
US$4,802,219 		32,890 -26.7% 141.88 US$4,802,219
2025-06-10 2025-06-06 B Purchase
2.3
Minai-Azary Jennifer Lynn

Chief Financial Officer

Officer
29,734 -15.3%
458.05
US$902,376 		29,734 -15.3% 458.05 US$902,376
2025-06-10 2025-06-06 B Purchase
3.3
Levit Alex C.

Chief Legal Officer, Corp. Sec

Officer
11,028 +47.9%
190.36
US$801,276 		11,028 +47.9% 190.36 US$801,276
2023-02-21 2023-02-21 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
5,823 +3.8%
0.84
US$4,900 		5,823 +3.8% 0.84 US$4,900
2023-02-13 2023-02-13 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
5,606 +3.8%
0.87
US$4,901 		5,606 +3.8% 0.87 US$4,901
2023-02-06 2023-02-06 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
5,040 +3.5%
0.97
US$4,900 		5,040 +3.5% 0.97 US$4,900
2023-01-30 2023-01-30 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
7,027 +5.2%
0.70
US$4,901 		7,027 +5.2% 0.70 US$4,901
2023-01-23 2023-01-23 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
6,839 +5.3%
0.72
US$4,901 		6,839 +5.3% 0.72 US$4,901
2023-01-18 2023-01-17 PP Planned purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
6,783 +5.5%
0.74
US$4,995 		6,783 +5.5% 0.74 US$4,995
2022-12-19 2022-12-16 B Purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
20,000 +19.5%
0.74
US$14,796 		20,000 +19.5% 0.74 US$14,796
2022-12-19 2022-12-16 B Purchase
2.3
Minai-Azary Jennifer Lynn

Chief Financial Officer

Officer
25,000 +166.7%
0.74
US$18,500 		25,000 +166.7% 0.74 US$18,500
2022-12-12 2022-12-09 B Purchase
3.3
Levit Alex C.

Chief Legal Officer, Corp. Sec

Officer
6,000 +200.0%
0.85
US$5,095 		6,000 +200.0% 0.85 US$5,095
2022-08-22 2022-08-19 B Purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
13,000 +14.5%
1.85
US$24,064 		13,000 +14.5% 1.85 US$24,064
2022-08-17 2022-08-17 B Purchase
2.3
Minai-Azary Jennifer Lynn

Chief Financial Officer

Officer
15,000 +inf%
1.80
US$27,000 		15,000 +inf% 1.80 US$27,000
2022-08-17 2022-08-16 B Purchase
0.5
Sahmoud Tarek

Chief Medical Officer

Officer
10,000 +inf%
1.95
US$19,500 		10,000 +inf% 1.95 US$19,500
2021-12-20 2021-12-16 B Purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
13,000 +1.6%
3.22
US$41,850 		13,000 +1.6% 3.22 US$41,850
2021-10-25 2021-10-22 B Purchase
3.3
Levit Alex C.

Chief Legal Officer, Corp. Sec

Officer
3,000 +inf%
5.00
US$15,000 		3,000 +inf% 5.00 US$15,000
2021-10-25 2021-10-22 B Purchase
2.2
Lehr Martin A.

Chief Executive Officer

Executive Director
10,000 +11.2%
5.00
US$50,000 		10,000 +11.2% 5.00 US$50,000
Explore more

More insider trading research around Context Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America